Key Quantitative Figures

Standalone Financial Results (Quarter Ended 30/09/2026):

  • Revenue from operations: ₹1,129.82 lakh
  • Other income: ₹(2.26) lakh
  • Total income: ₹1,127.56 lakh
  • Total expenses: ₹1,123.98 lakh
  • Profit before tax: ₹3.58 lakh
  • Tax expense: ₹0.00 lakh
  • Profit for the period: ₹3.58 lakh
  • Basic EPS: ₹0.01
  • Diluted EPS: ₹0.01

Standalone Financial Results (Half Year Ended 30/09/2026):

  • Revenue from operations: ₹2,043.91 lakh
  • Other income: ₹35.02 lakh
  • Total income: ₹2,078.93 lakh
  • Total expenses: ₹2,057.27 lakh
  • Profit before tax: ₹21.66 lakh
  • Tax expense: ₹3.57 lakh
  • Profit for the period: ₹18.09 lakh
  • Basic EPS: ₹0.05
  • Diluted EPS: ₹0.05

Consolidated Financial Results (Quarter Ended 30/09/2026):

  • Revenue from operations: ₹1,141.28 lakh
  • Other income: ₹(2.26) lakh
  • Total income: ₹1,139.02 lakh
  • Total expenses: ₹1,122.16 lakh
  • Profit before tax: ₹16.86 lakh
  • Tax expense: ₹3.22 lakh
  • Profit for the period: ₹13.64 lakh
  • Basic EPS: ₹0.03
  • Diluted EPS: ₹0.03

Consolidated Financial Results (Half Year Ended 30/09/2026):

  • Revenue from operations: ₹2,070.25 lakh
  • Other income: ₹35.02 lakh
  • Total income: ₹2,105.27 lakh
  • Total expenses: ₹2,070.17 lakh
  • Profit before tax: ₹35.10 lakh
  • Tax expense: ₹6.79 lakh
  • Profit for the period: ₹28.31 lakh
  • Basic EPS: ₹0.07
  • Diluted EPS: ₹0.07

Balance Sheet Position (Standalone as at 30/09/2026):

  • Total assets: ₹2,644.02 lakh
  • Share capital: ₹400.00 lakh
  • Other equity: ₹57.77 lakh
  • Non-current liabilities: ₹9.59 lakh
  • Current liabilities: ₹2,176.66 lakh
  • Inventories: ₹263.26 lakh
  • Trade receivables: ₹1,904.50 lakh
  • Cash and cash equivalents: ₹2.06 lakh

Cash Flow Statement (Standalone H1 FY27):

  • Net cashflow from operating activities: ₹(244.70) lakh
  • Net cashflow from investing activities: ₹69.25 lakh
  • Net cashflow from financing activities: ₹174.10 lakh
  • Net change in cash: ₹(1.35) lakh

Dates of Action

  • Board meeting date: 06th November, 2026
  • Meeting time: 03:30 PM to 04:50 PM
  • Financial period covered: Quarter and half year ended 30th September, 2026

Parties Involved

  • Auditor: Shivam Soni & Co., Chartered Accountants (FRN: 152477W)
  • Subsidiary: Vivanza Lifesciences Private Limited (included in consolidated results)
  • Stock exchange: BSE Limited

Segment Information

The Company operates only in a single segment i.e., pharmaceuticals related activities.

Audit Review

The limited review was conducted by Shivam Soni & Co., Chartered Accountants, who issued an unmodified review conclusion stating that nothing has come to their attention that causes them to believe that the financial results contain any material misstatement.

Capital Structure

Paid-up equity share capital remained unchanged at ₹400.00 lakh (face value of ₹1/- each) for all periods presented.